title: Comparable incremental value of standard and nonstandard lipids for coronary heart disease risk assessment in elderly adults: the Three City Study.
authors.forename: Celine
authors.initials: C
authors.lastname: Straczek
authors.forename: Helena
authors.initials: H
authors.lastname: Marti-Soler
authors.forename: Muriel
authors.initials: M
authors.lastname: Tafflet
authors.forename: Marie-Cecile
authors.initials: MC
authors.lastname: Perier
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Dupuy
authors.forename: Christophe
authors.initials: C
authors.lastname: Tzourio
authors.forename: Pascale
authors.initials: P
authors.lastname: Barberger-Gateau
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Empana
mesh_terms: D000368:Aged; D001054:Apolipoproteins A / Q000097:blood*; D001055:Apolipoproteins B / Q000097:blood*; D002097:C-Reactive Protein / Q000378:metabolism*; D003327:Coronary Disease / Q000097:blood*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy; D008055:Lipids / Q000097:blood*; D008297:Male; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D001054:Apolipoproteins A; D001055:Apolipoproteins B; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D002097:C-Reactive Protein